AHA · Chicago · 2026-11-06 – 2026-11-09

AHA Scientific Sessions 2026

1 di 21 studi Late-Breaking Science con risultato

I risultati sono sotto embargo fino a ciascuna presentazione e compaiono qui appena vengono resi noti.

ven 6 nov

08:35–09:50 (America/Chicago) · Center Stage, North Hall, Level 3

08:35ZEUSStudio clinicoPrimary Report of the Ziltivekimab Cardiovascular Outcomes Trial (ZEUS)Presentazione sab, 08:35
08:50Lp(a)HORIZON Studio chiaveCardiologia · Lipidi · Lipoproteina(a)In 8.323 pazienti con malattia cardiovascolare accertata e Lp(a) ≥70 mg/dL, pelacarsen 80 mg al mese non ha ridotto morte cardiovascolare, infarto miocardico, ictus o rivascolarizzazione urgente rispetto al placebo.Leggi →
09:00Lp(a)HORIZON extended analysesStudio osservazionaleExtended Analyses of Cardiovascular Outcomes With Pelacarsen Treatment in the Lp(a)Horizon TrialPresentazione sab, 09:00

13:45–14:45 (America/Chicago) · Center Stage, North Hall, Level 3

13:45OCEANIC-STROKE FraminghamStudio osservazionaleOutcomes in the OCEANIC-STROKE Randomized, Placebo-Controlled Trial: FXIa Inhibition by Asundexian in Participants With Non-Cardioembolic Stroke or Transient Ischemic Attack by Non-Laboratory Framingham Risk Score CategoryPresentazione sab, 13:45
14:00REDUCEStudio clinicoA Randomized Controlled Trial of Spironolactone-Based Blood Pressure Management After StrokePresentazione sab, 14:00
14:15OPTIMAL-StrokeStudio clinicoIntensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients With Prior Stroke: The OPTIMAL-Stroke TrialPresentazione sab, 14:15

15:15–16:30 (America/Chicago) · Center Stage, North Hall, Level 3

15:15STREAMStudio clinicoDiscontinuing Statins in Multimorbid Older Adults Without Cardiovascular Disease: A Randomized Non-Inferiority Clinical TrialPresentazione sab, 15:15
15:30OPTIMAL-DIABETESStudio clinicoIntensive Blood Pressure Control for the Prevention of Major Cardiovascular Events in Patients With Type 2 Diabetes - The OPTIMAL-DIABETES TrialPresentazione sab, 15:30
15:45Ez-PAVEStudio clinicoStatin-Ezetimibe Combination Therapy versus Statin Monotherapy in Patients With Atherosclerotic Cardiovascular Disease: Pre-Specified Second Randomization of the Ez-PAVE TrialPresentazione sab, 15:45
16:00Yoga-CaRe HFStudio clinicoYoga-Based Cardiac Rehabilitation in Heart Failure With Reduced Ejection FractionPresentazione sab, 16:00

15:30–16:45 (America/Chicago) · Center Stage, North Hall, Level 3

15:30OptimPacingStudio clinicoLeft Bundle Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block: An International Multi-Center Randomized Controlled Trial (OptimPacing Study)Presentazione dom, 15:30
15:45COAST-AFStudio clinicoCharacterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation: COAST-AF Randomized TrialPresentazione dom, 15:45
16:00SUPERIORStudio clinicoSacubitril/Valsartan for Preventing Recurrence of Atrial Fibrillation After Catheter Ablation in Patients With Hypertension: A Multicenter, Randomized Controlled TrialPresentazione dom, 16:00
16:15RACE-CARSStudio clinicoRandomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) Trial Primary ResultsPresentazione dom, 16:15

08:00–09:15 (America/Chicago) · Center Stage, North Hall, Level 3

08:00TYDAL-TIMI 78Studio clinicoTYDAL-TIMI 78: A Randomized Trial of ANGPTL4 Inhibition With MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol ConcentrationsPresentazione lun, 08:00
08:15CTX310Studio clinicoCRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3 for Severe Hypertriglyceridemia: Results From Phase 1b TrialPresentazione lun, 08:15
08:30ATTAIN-OSAStudio clinicoOrforglipron for the Treatment of Obstructive Sleep Apnea: Results From Attain-OSAPresentazione lun, 08:30
08:45SYNCHRONIZE-CVOTStudio clinicoSurvodutide and Cardiovascular Outcomes in Obesity: Results from the SYNCHRONIZE®-CVOT TrialPresentazione lun, 08:45

09:45–11:00 (America/Chicago) · Center Stage, North Hall, Level 3

09:55WATCH-LVStudio osservazionaleConsumer Smartwatch Artificial Intelligence-Enabled Electrocardiogram for Left Ventricular Systolic Dysfunction: Cross-Manufacturer Validation and Serial Home MonitoringPresentazione lun, 09:55
10:05PROVAR+Studio osservazionaleAI-Enabled Tele-ECG Identifies Structural Heart Disease and Prioritizes Echocardiography in Underserved Populations: The PROVAR+ External Validation StudyPresentazione lun, 10:05
10:22AI echo interpretation RCTStudio clinicoAI-Assisted Comprehensive Echocardiographic Interpretation—A Blinded, Randomized Controlled TrialPresentazione lun, 10:22